47.74.Z - Retail sale of medical and orthopedic products
47.73.Z - Retail sale of pharmaceutical products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | -0 | 0 | 155,2 |
Gross profit (loss) | 0 | -0 | 0 | 127,1 |
EBITDA | 0,1 | 0 | 0 | 195,2 |
Short time liabilities | 0,1 | 0,1 | 0,1 | 68,8 |
Other operating costs | 0 | 0 | 0 | 1183,2 |
Equity capital | 0,7 | 0,6 | 0,7 | 0,9 |
Operating profit (EBIT) | 0 | -0 | 0 | 148,1 |
Assets | 0,8 | 0,7 | 0,8 | 5,6 |
Net profit (loss) | 0 | -0 | 0 | 127,1 |
Cash | 0,3 | 0,4 | 0,5 | 18 |
Net income from sale | 1,7 | 1,6 | 1,8 | 9,5 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | 38,2 |
Working assets | 0,6 | 0,7 | 0,7 | 11,5 |
Other income costs | 0 | 0 | 0 | -67,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 5,7 | -3,5 | 0,9 | 4,4 |
Equity capital to total assets | 87,9 | 87,4 | 83,5 | -3,9 |
Gross profit margin | 2,6 | -1,4 | 0,3 | 1,7 |
EBITDA Margin | 4,9 | 0,9 | 2,4 | 1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 11 | 12 | 18 | 6 |
Current financial liquidity indicator | 12.465076446533203 | 12.615650177001953 | 8.332157135009766 | -4,3 |
Net dept to EBITDA | -3.707136869430542 | -23.749887466430664 | -9.662455558776855 | 14 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane